Development and comparison of iron dextran products

Area of Science:

• Pharmaceutical Science
• Drug Formulation
• Materials Science

Background:

• Iron dextran complex has been a parenteral drug formulation for forty years.
• Two new formulations have become available following the withdrawal of an older form in the US.

Purpose of the Study:

• To compare molecular weight, lot-to-lot consistency, and thermal stability of three iron dextran complex formulations.
• To assess particle size and degradation kinetics of different iron dextran preparations.

Main Methods:

• High-Performance Gel Permeation Chromatography (HP-GPC) for molecular weight and consistency analysis.
• Transmission Electron Microscopy (TEM) for particle size determination.
• Reduction degradation kinetics studies under thermal and acid stress.

Main Results:

• Significant differences were observed among the three iron dextran formulations.
• Variability and sensitivity to stress decreased from the oldest to the most recent formulation.
• The newest complex (265 kd +/- 1.5%) demonstrated superior consistency and stability over the older form (90 kd +/- 7.5%).

Conclusions:

• Improved manufacturing techniques and quality standards have led to more reproducible iron dextran complexes.
• The latest iron dextran formulations exhibit enhanced stability and reduced lot-to-lot variability.
• These advancements indicate higher quality parenteral iron dextran drug products.